Active ingredientVapendavirCat. No. P-V017-001CAS 439085-51-5Family · Pharmaceutical analytical standards
Vapendavir
An investigational oral antiviral that binds to the capsid of rhinoviruses, the common cold viruses, stopping them from attaching to cell receptors; in the 2010s it was studied mainly in adults with asthma. This family brings together the active ingredient and labelled standards.
Did you know?It was developed by an Australian research group based in the state of Victoria: in 2012 a study of 300 asthmatics at 48 US centres showed a significant reduction in cold symptoms compared with placebo.
Go to the active ingredient →Active ingredientVapendavirCat. No. P-V017-001CAS 439085-51-5
Isotopically labelledVapendavir-d5Cat. No. P-V017-002CAS 2738376-73-1No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.